Jounce Therapeutics, Inc.
JNCE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,919 | -$90,872 | -$43,842 | $56,823 |
| Dep. & Amort. | $2,087 | $2,827 | $3,401 | $3,851 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10,273 | $11,477 | $9,771 | $9,609 |
| Change in WC | $8,882 | -$7,847 | $2,835 | -$98,932 |
| Other Non-Cash | $800 | $921 | $47 | -$1,480 |
| Operating Cash Flow | -$28,877 | -$83,494 | -$27,788 | -$30,129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$919 | -$373 | -$94 | -$985 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$24,928 | -$130,272 | -$85,895 | -$188,999 |
| Inv. Sales/Matur. | $109,325 | $70,131 | $137,287 | $221,366 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $83,478 | -$60,514 | $51,298 | $31,382 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $442 | $90,826 | $70,142 | $3,645 |
| Stock Repurch. | $0 | $0 | $55,730 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $442 | $92,044 | $70,742 | $4,082 |
| Financing Cash Flow | $442 | $92,044 | $70,742 | $4,082 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $55,043 | -$51,964 | $94,252 | $5,335 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $96,799 | $148,763 | $54,511 | $49,176 |
| End Cash | $151,842 | $96,799 | $148,763 | $54,511 |
| Free Cash Flow | -$29,796 | -$83,867 | -$27,882 | -$31,114 |